APA

Parekh V., Sobanko J., Miller C. J., Karakousis G., Xu W., Letrero R., Elenitsas R., Xu X., Elder D. E., Amaravadi R., Schuchter L. M., Nathanson K. L., Wilson M. A. & Chu E. Y. (20190523). NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib. : Journal of cutaneous pathology.

Chicago

Parekh Vishwas, Sobanko Joseph, Miller Christopher J, Karakousis Giorgos, Xu Wei, Letrero Richard, Elenitsas Rosalie, Xu Xiaowei, Elder David E, Amaravadi Ravi, Schuchter Lynn M, Nathanson Katherine L, Wilson Melissa A and Chu Emily Y. 20190523. NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib. : Journal of cutaneous pathology.

Harvard

Parekh V., Sobanko J., Miller C. J., Karakousis G., Xu W., Letrero R., Elenitsas R., Xu X., Elder D. E., Amaravadi R., Schuchter L. M., Nathanson K. L., Wilson M. A. and Chu E. Y. (20190523). NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib. : Journal of cutaneous pathology.

MLA

Parekh Vishwas, Sobanko Joseph, Miller Christopher J, Karakousis Giorgos, Xu Wei, Letrero Richard, Elenitsas Rosalie, Xu Xiaowei, Elder David E, Amaravadi Ravi, Schuchter Lynn M, Nathanson Katherine L, Wilson Melissa A and Chu Emily Y. NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib. : Journal of cutaneous pathology. 20190523.